# C_2009132EN.01001501.xml

| 11.6.2009 | EN | Official Journal of the European Union | C 132/15 |
| --- | --- | --- | --- |

11.6.2009

EN

Official Journal of the European Union

C 132/15

---

Prior notification of a concentration

(Case COMP/M.5476 — PFIZER/WYETH)

(Text with EEA relevance)

2009/C 132/08

| 1. | On 29 May 2009 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Pfizer Inc. (‘Pfizer’), a corporation incorporated under the laws of the State of Delaware, U.S.A., proposes to acquire sole control within the meaning of Article 3(1)(b) of the Council Regulation of Wyeth, a corporation incorporated under the laws of the State of Delaware, U.S.A. (‘Wyeth’), by way of purchase of shares. |
| --- | --- |

1.

On 29 May 2009 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Pfizer Inc. (‘Pfizer’), a corporation incorporated under the laws of the State of Delaware, U.S.A., proposes to acquire sole control within the meaning of Article 3(1)(b) of the Council Regulation of Wyeth, a corporation incorporated under the laws of the State of Delaware, U.S.A. (‘Wyeth’), by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | Pfizer is a global research based biomedical and pharmaceutical company active in discovering, developing, manufacturing, marketing, and selling innovative medicines for humans and animals, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

Pfizer is a global research based biomedical and pharmaceutical company active in discovering, developing, manufacturing, marketing, and selling innovative medicines for humans and animals,

| — | Wyeth is a pharmaceutical and healthcare company active in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines worldwide. The company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Heath. |
| --- | --- |

—

Wyeth is a pharmaceutical and healthcare company active in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines worldwide. The company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Heath.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 2 2964301 or 2967244) or by post, under reference number COMP/M.5476 — PFIZER/WYETH, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 2 2964301 or 2967244) or by post, under reference number COMP/M.5476 — PFIZER/WYETH, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---